Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models.
J Med Econ
; 23(3): 221-227, 2020 Mar.
Article
in En
| MEDLINE
| ID: mdl-31835974
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Cost-Benefit Analysis
/
Models, Economic
/
Anti-Retroviral Agents
Type of study:
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
J Med Econ
Journal subject:
SERVICOS DE SAUDE
Year:
2020
Document type:
Article
Affiliation country:
Sudáfrica
Country of publication:
Reino Unido